Moira Muller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Objective To compare the effectiveness of cervical pessary and vaginal progesterone in the prevention of adverse perinatal outcomes and preterm birth in pregnant women of singletons with no prior spontaneous preterm birth at less than 34 weeks’ gestation and who have a short cervix of 35 mm or less.

Design Open label, multicentre, randomised, controlled trial.

Setting 20 hospitals and five obstetric ultrasound practices in the Netherlands.

Participants Women with a healthy singleton pregnancy and an asymptomatic short cervix of 35 mm or less between 18 and 22 weeks’ gestation were eligible. Exclusion criteria were prior spontaneous preterm birth at less than 34 weeks, a cerclage in situ, maternal age of younger than 18 years, major congenital abnormalities, prior participation in this trial, vaginal blood loss, contractions, cervical length of less than 2 mm or cervical dilatation of 3 cm or more. Sample size was set at 628 participants.

Interventions 1: ....

Noord Holland , Noord Brabant , Zuid Holland , Moira Muller , Karlijnc Vollebregt , Joris Van Drongelen , Brendaj Hermsen , Brendam Kazemier , Eva Pajkrt , Stichting Stoptevroegbevallen , Martijna Oudijk , Bouchra Koullali , Henricus Visser , Quadruplep Research Group , International Clinical Trial Registry Platform , Core Outcomes In Women Health , Quadruplep Research , European Foundation , Score Outcomes , Middle Eastern , South Asian , Stichting Stoptevroegbevallen ,